I agree that this site is using cookies. You can find further informations here.
X
Raschi, E.
164  results:
Search for persons X
?
1

Pharmacovigilance analysis of the Vigibase on neonatal with..:

Gastaldon, C. ; Arzenton, E. ; Raschi, E....
European Psychiatry.  66 (2023)  S1 - p. S96-S96 , 2023
Link: https://doi.org/10.1192/..
 
?
2

The real-world safety profile of SGLT2 inhibitors among adu..:

Goldman, A ; Fishman, B ; Raschi, E...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
3

Neonatal withdrawal syndrome following in utero exposure to..:

Gastaldon, C. ; Arzenton, E. ; Raschi, E....
Psychological Medicine.  53 (2022)  12 - p. 5645-5653 , 2022
Link: https://doi.org/10.1017/..
 
?
4

Safety of esketamine nasal spray: Analysis of post-marketin..:

Gastaldon, C. ; Raschi, E. ; Kane, J..
European Psychiatry.  64 (2021)  S1 - p. S150-S151 , 2021
Link: https://doi.org/10.1192/..
 
?
5

Reduced reporting of neuropsychiatric adverse events with t..:

Raschi, E. ; Salvo, F. ; La Placa, M...
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  8 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
6

The value of case reports and spontaneous reporting systems..:

Raschi, E. ; La Placa, M. ; Poluzzi, E..
British Journal of Dermatology.  184 (2020)  3 - p. 581-583 , 2020
Link: https://doi.org/10.1111/..
 
?
7

PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVAL..:

Lunghi, C. ; Antonazzo, I.C. ; Poluzzi, E....
Value in Health.  22 (2019)  - p. S231 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Pharmacovigilance of sodium-glucose co-transporter-2 inhibi..:

Raschi, E. ; Poluzzi, E. ; Salvo, F....
Nutrition, Metabolism and Cardiovascular Diseases.  28 (2018)  6 - p. 533-542 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Association between the use of proton pump inhibitors and c..:

Raschi, E. ; Bianchin, M. ; Poluzzi, E..
Neurogastroenterology & Motility.  29 (2017)  2 - p. , 2017
Link: https://doi.org/10.1111/..
 
?
10

Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitor..:

Raschi, E. ; Parisotto, M. ; Forcesi, E....
Clinical Therapeutics.  39 (2017)  8 - p. e38-e39 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Adverse events with sodium-glucose co-transporter-2 inhibit..:

Raschi, E. ; Parisotto, M. ; Forcesi, E....
Nutrition, Metabolism and Cardiovascular Diseases.  27 (2017)  12 - p. 1098-1107 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Pattern of drug use among preterm neonates: results from an..:

Girardi, A. ; Galletti, S. ; Raschi, E....
Italian Journal of Pediatrics.  43 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
13

Dipeptidyl peptidase-4 inhibitors and heart failure: Analys..:

Raschi, E. ; Poluzzi, E. ; Koci, A....
Nutrition, Metabolism and Cardiovascular Diseases.  26 (2016)  5 - p. 380-386 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Hospitalisations by Drug interactions with nsaids in elderl..:

Piccinni, C. ; Lionello, L. ; Raschi, E....
Clinical Therapeutics.  37 (2015)  8 - p. e101-e102 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors..:

Raschi, E. ; Poluzzi, E. ; Koci, A...
Clinical Therapeutics.  37 (2015)  8 - p. e106 , 2015
Link: https://doi.org/10.1016/..
 
1-15